EQUITY RESEARCH MEMO

Tenex Health

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

Tenex Health is a medical device company based in Lake Forest, California, focused on providing minimally invasive solutions for chronic tendon and bone spur pain. The company's Tenex 2nd Generation System, now marketed under Trice Medical, offers a clinically proven procedure for patients who have failed conservative treatment for three months or more. By utilizing ultrasonic technology, Tenex allows physicians to precisely remove damaged tissue while preserving healthy structures, reducing recovery time compared to traditional surgery. The platform's expanded capabilities and new features aim to broaden its applicability across various orthopedic conditions, positioning Tenex as a key player in the interventional pain management space. With a growing base of trained physicians and a shift toward value-based care, Tenex Health is poised to capture significant market share in the chronic pain treatment segment.

Upcoming Catalysts (preview)

  • Q3 2026FDA Clearance for Expanded Indications of Tenex 2nd Generation System75% success
  • Q4 2026Publication of Peer-Reviewed Clinical Outcomes Study for Tenex Procedure70% success
  • Q1 2027Strategic Partnership or Distribution Agreement for Tenex Technology60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)